Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing’s Sarcoma (EWS/FLI1) and Wilms’ Tumor(WT1)

Vivek Subbiah; Robert E. Brown; Yunyun Jiang; Jamie Buryanek; Andrea Hayes-Jordan; Razelle Kurzrock; Pete M. Anderson

doi:10.1371/journal.pone.0068985

Loading metrics

Open Access

Peer-reviewed

Research Article

Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing’s Sarcoma (EWS/FLI1) and Wilms’ Tumor(WT1)

Vivek Subbiah ,

Contributed equally to this work with: Vivek Subbiah, Robert E. Brown, Razelle Kurzrock, Pete M. Anderson

* E-mail: vsubbiah@mdanderson.org

Affiliation Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Robert E. Brown ,

Contributed equally to this work with: Vivek Subbiah, Robert E. Brown, Razelle Kurzrock, Pete M. Anderson

Affiliation Department of Pathology and Laboratory Medicine, University of Texas Health Science Center-Medical School at Houston, Houston, Texas, United States of America
⨯
Yunyun Jiang,

Affiliation Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Jamie Buryanek,

Affiliation Department of Pathology and Laboratory Medicine, University of Texas Health Science Center-Medical School at Houston, Houston, Texas, United States of America
⨯
Andrea Hayes-Jordan,

Affiliation Department of Surgical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America
⨯
Razelle Kurzrock ,

Contributed equally to this work with: Vivek Subbiah, Robert E. Brown, Razelle Kurzrock, Pete M. Anderson

Affiliations Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, United States of America, Center for Personalized Therapy & Clinical Trials Office, Division of Hematology & Oncology, University of California San Diego - Moores Cancer Center, La Jolla, California, United States of America
⨯
Pete M. Anderson

Contributed equally to this work with: Vivek Subbiah, Robert E. Brown, Razelle Kurzrock, Pete M. Anderson

Affiliation Pediatric Hematology/Oncology/BMT, Levine Children’s Hospital/Levine Cancer Institute, Charlotte, North Carolina, United States of America
⨯

Morphoproteomic Profiling of the Mammalian Target of Rapamycin (mTOR) Signaling Pathway in Desmoplastic Small Round Cell Tumor (EWS/WT1), Ewing’s Sarcoma (EWS/FLI1) and Wilms’ Tumor(WT1)

Vivek Subbiah,
Robert E. Brown,
Yunyun Jiang,
Jamie Buryanek,
Andrea Hayes-Jordan,
Razelle Kurzrock,
Pete M. Anderson

Published: July 29, 2013
https://doi.org/10.1371/journal.pone.0068985

Reader Comments (0)

Post a new comment on this article

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Ewing sarcoma
Is the Subject Area "Ewing sarcoma" applicable to this article?

Thanks for your feedback.
Cancers and neoplasms
Is the Subject Area "Cancers and neoplasms" applicable to this article?

Thanks for your feedback.
ERK signaling cascade
Is the Subject Area "ERK signaling cascade" applicable to this article?

Thanks for your feedback.
Malignant tumors
Is the Subject Area "Malignant tumors" applicable to this article?

Thanks for your feedback.
Nephroblastoma
Is the Subject Area "Nephroblastoma" applicable to this article?

Thanks for your feedback.
Renal cancer
Is the Subject Area "Renal cancer" applicable to this article?

Thanks for your feedback.
Cancer treatment
Is the Subject Area "Cancer treatment" applicable to this article?

Thanks for your feedback.
Chromosomal translocations
Is the Subject Area "Chromosomal translocations" applicable to this article?

Thanks for your feedback.